{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:07:45Z","timestamp":1793250465706,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1053\/j.gastro.2017.01.031","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T07:07:14Z","timestamp":1488352034000},"page":"706-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":798,"title":["The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association"],"prefix":"10.1053","volume":"152","author":[{"given":"Daniel E.","family":"Freedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2017.01.031_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in Prescription Drug Use Among Adults in the United States From 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association medical position statement on the management of Barrett's esophagus","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ajg.2015.322","article-title":"ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus","volume":"111","author":"Shaheen","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib7","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/j.1572-0241.2008.02216.x","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"103","author":"Bhatt","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","article-title":"Systematic review: Proton pump inhibitor-associated acute interstitial nephritis","volume":"26","author":"Sierra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib10","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015121377","article-title":"Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD","author":"Xie","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2017.01.031_bib11","doi-asserted-by":"crossref","first-page":"e58837","DOI":"10.1371\/journal.pone.0058837","article-title":"The proton-pump inhibitor lansoprazole enhances amyloid beta production","volume":"8","author":"Badiola","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.01.031_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","article-title":"Risk of dementia in elderly patients with the use of proton pump inhibitors","volume":"265","author":"Haenisch","year":"2015","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1053\/j.gastro.2017.01.031_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.gastro.2017.01.031_bib14","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2013.09.014","article-title":"Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals","volume":"57","author":"Maggio","year":"2013","journal-title":"Bone"},{"key":"10.1053\/j.gastro.2017.01.031_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(15)30516-3","article-title":"Comparing Bone Structure and Bone Metabolism Between Long-Term Proton Pump Inhibitor Users and Non-Users","volume":"148","author":"Targownik","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"10.1053\/j.gastro.2017.01.031_bib20","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.01.031_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jama.1927.02690100051014","article-title":"Host susceptability to typhoid, dysentery, food poisoning and diarrhea","volume":"89","author":"Arnold","year":"1927","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2036.1998.00275.x","article-title":"Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly","volume":"12","author":"Pereira","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2036.1996.d01-506.x","article-title":"Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole","volume":"10","author":"Lewis","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.01.031_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM195609202551203","article-title":"Association of Salmonella enteritis with operations on the stomach","volume":"255","author":"Kunz","year":"1956","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ajg.2013.30","article-title":"Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data","volume":"108","author":"Brophy","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib28","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.4238\/2015.July.3.25","article-title":"Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis","volume":"14","author":"Xu","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1053\/j.gastro.2017.01.031_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1053\/j.gastro.2017.01.031_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/ice.2014.39","article-title":"Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Furuya-Kanamori","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/j.gastro.2017.01.031_bib32","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1086\/523582","article-title":"Clostridium difficile\u2013associated disease in a setting of endemicity: identification of novel risk factors","volume":"45","author":"Dubberke","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2017.01.031_bib33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/cid\/civ432","article-title":"Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study","volume":"61","author":"Freedberg","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2017.01.031_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jpeds.2014.12.067","article-title":"16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora","volume":"166","author":"Rosen","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1053\/j.gastro.2017.01.031_bib35","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.01.031_bib36","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-149-6-200809160-00005","article-title":"Proton-pump inhibitor use and the risk for community-acquired pneumonia","volume":"149","author":"Sarkar","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/hrt.2010.217547","article-title":"Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)","volume":"97","author":"Scheiman","year":"2011","journal-title":"Heart"},{"key":"10.1053\/j.gastro.2017.01.031_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/apt.13304","article-title":"Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies","volume":"42","author":"Estborn","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00134-013-3125-3","article-title":"Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"40","author":"Krag","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"American Journal of Medicine"},{"key":"10.1053\/j.gastro.2017.01.031_bib42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-66-5-917","article-title":"The absorption of calcium carbonate","volume":"66","author":"Ivanovich","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/07315724.1995.10718522","article-title":"Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans","volume":"14","author":"Serfaty-Lacrosniere","year":"1995","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1053\/j.gastro.2017.01.031_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2036.1998.00274.x","article-title":"Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy","volume":"12","author":"Stewart","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1053\/j.gastro.2017.01.031_bib45","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/gut.2006.108613","article-title":"Proton pump inhibitors suppress absorption of dietary non-haem iron\u00a0in hereditary haemochromatosis","volume":"56","author":"Hutchinson","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.01.031_bib46","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib47","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"key":"10.1053\/j.gastro.2017.01.031_bib48","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2036.2008.03601.x","article-title":"Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals","volume":"27","author":"den Elzen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK","volume":"55","author":"Garcia Rodriguez","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.01.031_bib51","first-page":"CD010623","article-title":"Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions","volume":"12","author":"Song","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.01.031_bib52","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.13194","article-title":"Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies","volume":"41","author":"Attwood","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib53","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1172\/JCI118993","article-title":"Processing and proliferative effects of human progastrin in transgenic mice","volume":"98","author":"Wang","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2017.01.031_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.2910430425","article-title":"The in\u00a0vitro growth response of primary human colorectal and gastric cancer cells to gastrin","volume":"43","author":"Watson","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.01.031_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0016-5085(98)70193-3","article-title":"Gastrin and colorectal cancer: a prospective study","volume":"115","author":"Thorburn","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/j.gastro.2007.06.014","article-title":"Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study","volume":"133","author":"Robertson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib57","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.1935.02760110034008","article-title":"Peptic esophagitis: a new clinical entity","volume":"104","author":"Winkelstein","year":"1935","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.01.031_bib58","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A\u00a0comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib59","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/0016-5085(94)90532-0","article-title":"A\u00a0comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group","volume":"107","author":"Smith","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2036.2004.01928.x","article-title":"Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial","volume":"19","author":"Krol","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib61","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2036.1999.00564.x","article-title":"On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis\u2013a placebo-controlled randomized trial","volume":"13","author":"Lind","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2036.2007.03381.x","article-title":"Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'","volume":"26","author":"Pace","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-9610(85)80031-3","article-title":"Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux","volume":"149","author":"Sarr","year":"1985","journal-title":"Am J Surg"},{"key":"10.1053\/j.gastro.2017.01.031_bib64","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","article-title":"Screening for Barrett's esophagus in colonoscopy patients with and\u00a0without heartburn","volume":"125","author":"Rex","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib65","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1572-0241.2005.41364.x","article-title":"Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey","volume":"100","author":"Chey","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib66","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.01.031_bib69","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2017.01.031_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","article-title":"Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release","volume":"10","author":"Fass","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.01.031_bib71","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/gast.2001.28649","article-title":"Step-down management of gastroesophageal reflux disease","volume":"121","author":"Inadomi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.2005.02553.x","article-title":"Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis","volume":"22","author":"Sjostedt","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.01.031_bib73","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/gut.2005.087668","article-title":"Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring","volume":"55","author":"Mainie","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.01.031_bib74","first-page":"CD006095","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"5","author":"Goldenberg","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2017.01.031_bib75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib76","first-page":"817","article-title":"Estimation of total usual calcium and vitamin D intakes in the United States","volume":"140","author":"Bailey","year":"2010","journal-title":"J\u00a0Nutr"},{"key":"10.1053\/j.gastro.2017.01.031_bib77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2017.01.031_bib78","first-page":"495","article-title":"Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014","volume":"64","author":"Crim","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.gastro.2017.01.031_bib79","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.01.031_bib80","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.01.031_bib81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.111.015222","article-title":"Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12","volume":"94","author":"Bailey","year":"2011","journal-title":"Am J Clin Nutr"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517300914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517300914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:21:45Z","timestamp":1719069705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508517300914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0016508517300914"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2017.01.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727370420.793536966","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2017.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}